Paperplane Therapeutics has raised $1.5 million to deal with sufferers for ache and anxiousness utilizing digital actuality, probably making journeys to the dentist extra nice.
The Montreal, Canada-based firm speciliazes in therapeutic digital actuality options for ache and anxiousness administration in healthcare.
Glen Ventures led the spherical, with monetary assist from the Gouvernement du Québec by way of Investissement Québec. Strategic traders comparable to CABHI (Centre for Growing old + Mind Well being Innovation), Cedars-Sinai Mental Property Firm, Anges Québec, and Aventure Capital additionally participated.
Ache and anxiousness pose main obstacles for sufferers in search of medical care, typically resulting in delays, elevated discomfort, and extra complicated therapies. This situation is especially prevalent in dentistry, the place roughly 36% of people expertise anxiousness throughout dental visits, 12% undergo from excessive dental worry, and 22% postpone appointments till ache forces them to hunt care, leading to elevated prices and issues.
With this in thoughts, Paperplane is specializing in the North American dental market, aiming to boost affected person experiences and scientific workflows by way of its therapeutic digital actuality options.
Paperplane’s know-how addresses this problem by remodeling dental procedures—typically perceived as painful and traumatic—into extra manageable, even nice experiences by way of immersive digital actuality.
Designed for sufferers of all ages, with a specific emphasis on pediatric care, Paperplane’s options assist make sufferers extra snug. Paperplane additionally streamlines scientific workflows and reduces the burden on clinicians.
“As an emergency doctor, I’ve seen firsthand the dearth of choices obtainable for managing ache and anxiousness,” mentioned Jean-Simon Fortin, CEO of Paperplane Therapeutics, in an announcement. “In the present day, I’m proud to see our VR know-how filling that hole, offering healthcare professionals with a more practical option to assist their sufferers. This funding will enable us to increase our attain, enabling much more clinicians to ship really transformative care.”
This funding marks a big milestone in Paperplane’s development and it’ll allow the corporate to proceed its mission of deploying digital actuality therapies within the dental sector, bettering each affected person outcomes and care supply throughout North America. Moreover, this funding will assist Paperplane’s enlargement into Europe by way of a strategic partnership with French firm HypnoVR, backed by its CE Mark certification.
Michael Goodman, founding companion at Glen Ventures, mentioned in an announcement, “Paperplane is redefining how we strategy ache and anxiousness administration in healthcare. Their VR options not solely improve affected person consolation but additionally contribute to extra environment friendly scientific workflows. We’re proud to assist an organization that’s elevating the usual of affected person care whereas pushing the boundaries of medical innovation.”
Christopher Skeete, Quebec’s Minister for the Economic system and Minister Liable for the Combat Towards Racism, mentioned in an announcement, “Quebec’s ingenuity has the facility to form the way forward for our healthcare system, and Paperplane Therapeutics is a major instance. Our authorities is proud to assist the event of options that enhance each the standard and accessibility of affected person care.”
“Paperplane Therapeutics helps place Quebec as a frontrunner in medical know-how innovation by way of its digital actuality options,” added Bicha Ngo, CEO of Investissement Québec, in an announcement. “By rethinking the affected person expertise, the corporate demonstrates the immense potential of Quebec’s healthcare innovation ecosystem. With this funding, they now have the assets to speed up their development.”
